{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:11:05Z","timestamp":1789607465804,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04811-6","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:14:53Z","timestamp":1771064093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["From glucosuria to dialysis: a case report of osmotic nephropathy due to an SGLT2 inhibitor"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6637-6057","authenticated-orcid":false,"given":"Juan","family":"Castellanos-de la Hoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5927-7528","authenticated-orcid":false,"given":"Alejandra","family":"Molano-Trivi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1414-4375","authenticated-orcid":false,"given":"Yesid Felipe","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4310-2894","authenticated-orcid":false,"given":"Lina Maria","family":"Espinosa Saltaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9447-4407","authenticated-orcid":false,"given":"Eduardo","family":"Z\u00fa\u00f1iga-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"issue":"3","key":"4811_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.47102\/annals-acadmedsg.2020526","volume":"50","author":"CSM Sia","year":"2021","unstructured":"Sia CSM, Leong LCY, Wong ETY, Goh GH, Leo CCH. Empagliflozin-induced severe osmotic nephrosis and acute renal injury in advanced chronic kidney disease. Ann Acad Med Singap. 2021;50(3):255\u20137.","journal-title":"Ann Acad Med Singap"},{"issue":"5","key":"4811_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1053\/j.ajkd.2023.09.017","volume":"83","author":"N Krishnan","year":"2024","unstructured":"Krishnan N, Moledina DG, Perazella MA. Toxic nephropathies of the tubulointerstitium: core curriculum 2024. Am J Kidney Dis. 2024;83(5):659\u201376.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"4811_CR3","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2215\/CJN.11290821","volume":"17","author":"MA Perazella","year":"2022","unstructured":"Perazella MA, Rosner MH. Drug-Induced acute kidney injury. Clin J Am Soc Nephrol. 2022;17(8):1220\u201333.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4811_CR4","doi-asserted-by":"crossref","unstructured":"Zhou C, Yool AJ, Nolan J, Byard RW. Armanni-Ebstein lesions: a need for clarification. J Forensic Sci. 2013;58(s1).","DOI":"10.1111\/j.1556-4029.2012.02274.x"},{"issue":"12","key":"4811_CR5","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.2215\/CJN.00150118","volume":"13","author":"MA Perazella","year":"2018","unstructured":"Perazella MA. Pharmacology behind common drug nephrotoxicities. Clin J Am Soc Nephrol. 2018;13(12):1897\u2013908.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4811_CR6","doi-asserted-by":"crossref","unstructured":"Perazella MA, Juncos LA. Drug-Induced osmotic nephropathy: add SGLT2-Inhibitors to the list? Kidney360. 2022;3(3):550\u20133.","DOI":"10.34067\/KID.0007882021"},{"issue":"3","key":"4811_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1053\/j.ajkd.2007.10.044","volume":"51","author":"M Dickenmann","year":"2008","unstructured":"Dickenmann M, Oettl T, Mihatsch MJ. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis. 2008;51(3):491\u2013503.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"4811_CR8","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.numecd.2017.10.011","volume":"27","author":"A Perlman","year":"2017","unstructured":"Perlman A, Heyman SN, Matok I, Stokar J, Muszkat M, Szalat A. Acute renal failure with sodium-glucose-cotransporter-2 inhibitors: analysis of the FDA adverse event report system database. Nutr Metabolism Cardiovasc Dis. 2017;27(12):1108\u201313.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"key":"4811_CR9","doi-asserted-by":"publisher","unstructured":"Yu T, Xiao J, Li M, Cheng SQ, Cai R, Huang L, Yu H, Li JY, Zhang YY, Wang Y. Risk of acute renal failure associated with combined use of SGLT2 inhibitors and potentially nephrotoxic drugs: an epidemiological surveillance study based on the FDA adverse event reporting system (FAERS). Expert Opin Drug Saf 2025 Mar 2:1\u201312. doi: https:\/\/doi.org\/10.1080\/14740338.2025.2471529. Epub ahead of print. PMID: 39985753.","DOI":"10.1080\/14740338.2025.2471529"},{"issue":"4S","key":"4811_CR10","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","journal-title":"Kidney Int"},{"key":"4811_CR11","doi-asserted-by":"publisher","unstructured":"Shi FH, Li H, Yue J, Jiang YH, Gu ZC, Ma J, Lin HW. Clinical adverse events of high-dose vs low-dose sodium\u2013glucose cotransporter 2 inhibitors in type 2 diabetes: a meta-analysis of 51 randomized clinical trials. J Clin Endocrinol Metab. 2020;105(11):dgaa586. https:\/\/doi.org\/10.1210\/clinem\/dgaa586. PMID: 32841351.","DOI":"10.1210\/clinem\/dgaa586"},{"key":"4811_CR12","doi-asserted-by":"publisher","unstructured":"Lin DS, Lee JK, Chen WJ. Clinical Adverse Events Associated with Sodium-Glucose Cotransporter 2 Inhibitors: a meta-analysis involving 10 randomized Clinical Trials and 71 553 Individuals. J Clin Endocrinol Metab. 2021;106(7):2133\u20132145. https:\/\/doi.org\/10.1210\/clinem\/dgab274. PMID: 33895840.","DOI":"10.1210\/clinem\/dgab274"},{"issue":"1","key":"4811_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s13730-025-01052-8","volume":"15","author":"A Murata","year":"2026","unstructured":"Murata A, et al. Osmotic nephropathy as a potentially underrecognized cause of acute kidney injury during SGLT2 inhibitor therapy: a case report and literature review. CEN Case Rep. 2026;15(1):16.","journal-title":"CEN Case Rep"},{"issue":"1","key":"4811_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1053\/j.ajkd.2020.01.015","volume":"76","author":"G Phadke","year":"2020","unstructured":"Phadke G, Kaushal A, Tolan DR, Hahn K, Jensen T, Bjornstad P, et al. Osmotic nephrosis and acute kidney injury associated with SGLT2 inhibitor use: A case report. Am J Kidney Dis. 2020;76(1):144\u20137.","journal-title":"Am J Kidney Dis"},{"key":"4811_CR15","doi-asserted-by":"publisher","unstructured":"Ariga M, Hagita J, Soda M, Oida Y, Teramachi H, Kitaichi K. Daily dose of metformin caused acute kidney injury with lactic acidosis: a case report. J Med Case Rep. 2023;17(1):393. https:\/\/doi.org\/10.1186\/s13256-023-04136-0. PMID: 37715272.","DOI":"10.1186\/s13256-023-04136-0"},{"key":"4811_CR16","doi-asserted-by":"publisher","unstructured":"Arroyo D, Melero R, Panizo N, Goicoechea M, Rodr\u00edguez Ben\u00edtez P, Garc\u00eda Vinuesa S, Verde E, Tejedor A, Lu\u00f1o J. Metformin associated acute kidney injury and lactic acidosis. Int J Nephrol. 2011;2011:749653. https:\/\/doi.org\/10.4061\/2011\/749653. PMID: 21792389.","DOI":"10.4061\/2011\/749653"},{"key":"4811_CR17","doi-asserted-by":"publisher","unstructured":"Song A, Zhang C, Meng X. Mechanism and application of metformin in kidney diseases: an update. Biomed Pharmacother. 2021;138:111454. https:\/\/doi.org\/10.1016\/j.biopha.2021.111454. Epub 2021 Mar 11. PMID: 33714781.","DOI":"10.1016\/j.biopha.2021.111454"},{"issue":"11","key":"4811_CR18","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.ekir.2020.08.026","volume":"5","author":"Y Wen","year":"2020","unstructured":"Wen Y, Yang C, Menez SP, Rosenberg AZ, Parikh CR. A systematic review of clinical characteristics and histologic descriptions of acute tubular injury. Kidney Int Rep. 2020;5(11):1993\u20132001. PMID: 33163720; PMCID: PMC7609907.","journal-title":"Kidney Int Rep"},{"key":"4811_CR19","doi-asserted-by":"publisher","unstructured":"Hoshi MKS, Jain M, Gaut S. JP. Renal histopathologic findings associated with severity of clinical acute kidney injury. Am J Surg Pathol. 2018;42(5):625\u2013635. https:\/\/doi.org\/10.1097\/PAS.0000000000001028. PMID: 29537990.","DOI":"10.1097\/PAS.0000000000001028"},{"issue":"4","key":"4811_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/qjmed\/hct258","volume":"107","author":"AM Hall","year":"2014","unstructured":"Hall AM, Bass P, Unwin RJ. Drug-induced renal Fanconi syndrome. QJM. 2014;107(4):261\u20139.","journal-title":"QJM"},{"issue":"1","key":"4811_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/0886022X.2017.1419973","volume":"40","author":"J Shi","year":"2018","unstructured":"Shi J, Qian J, Li H, Luo H, Luo W, Lin Z. Renal tubular epithelial cells injury induced by mannitol and its potential mechanism. Ren Fail. 2018;40(1):85\u201391.","journal-title":"Ren Fail"},{"issue":"2","key":"4811_CR22","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1053\/j.ajkd.2016.12.003","volume":"69","author":"AB Fogo","year":"2017","unstructured":"Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD atlas of renal pathology: osmotic tubular injury. Am J Kidney Dis. 2017;69(2):e11\u20132.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4811_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/1556-4029.13235","volume":"62","author":"C Zhou","year":"2017","unstructured":"Zhou C, Vink R, Byard RW. Hyperosmolarity induces Armanni-Ebstein\u2010like renal tubular epithelial swelling and cytoplasmic vacuolization. J Forensic Sci. 2017;62(1):229\u201332.","journal-title":"J Forensic Sci"},{"issue":"5","key":"4811_CR24","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1111\/1556-4029.15321","volume":"68","author":"FM Auld","year":"2023","unstructured":"Auld FM, Parai JL, Milroy CM. Subnuclear renal tubular vacuoles in alcohol use disorder. J Forensic Sci. 2023;68(5):1759\u201367.","journal-title":"J Forensic Sci"},{"issue":"3","key":"4811_CR25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/1556-4029.13311","volume":"62","author":"C Zhou","year":"2017","unstructured":"Zhou C, Yool AJ, Byard RW. Basal vacuolization in renal tubular epithelial cells at autopsy and their relation to ketoacidosis. J Forensic Sci. 2017;62(3):681\u20135.","journal-title":"J Forensic Sci"},{"key":"4811_CR26","doi-asserted-by":"crossref","unstructured":"Nakamura J, Yamamoto T, Takabatake Y, Namba-Hamano T, Minami S, Takahashi A et al. TFEB-mediated lysosomal exocytosis alleviates high-fat diet\u2013induced lipotoxicity in the kidney. JCI Insight. 2023;8(4).","DOI":"10.1172\/jci.insight.162498"},{"issue":"3","key":"4811_CR27","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/1556-4029.12711","volume":"60","author":"C Zhou","year":"2015","unstructured":"Zhou C, Moore L, Yool A, Jaunzems A, Byard RW. Renal tubular epithelial Vacuoles\u2014A marker for both hyperlipidemia and ketoacidosis at autopsy. J Forensic Sci. 2015;60(3):638\u201341.","journal-title":"J Forensic Sci"},{"issue":"3","key":"4811_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.semarthrit.2004.06.003","volume":"34","author":"H Orbach","year":"2004","unstructured":"Orbach H, Tishler M, Shoenfeld Y. Intravenous Immunoglobulin and the kidney\u2014a two-edged sword. Semin Arthritis Rheum. 2004;34(3):593\u2013601.","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"4811_CR29","doi-asserted-by":"publisher","first-page":"e0261345","DOI":"10.1371\/journal.pone.0261345","volume":"16","author":"T Miyano","year":"2021","unstructured":"Miyano T, Suzuki A, Sakamoto N. Hyperosmotic stress induces epithelial-mesenchymal transition through rearrangements of focal adhesions in tubular epithelial cells. PLoS ONE. 2021;16(12):e0261345. https:\/\/doi.org\/10.1371\/journal.pone.0261345. PMID: 34932568; PMCID: PMC8691603.","journal-title":"PLoS ONE"},{"key":"4811_CR30","doi-asserted-by":"publisher","unstructured":"Matsushita K, Takasu S, Kuroda K, Ishii Y, Kijima A, Ogawa K, Umemura T. Mechanisms underlying exacerbation of osmotic nephrosis caused by pre-existing kidney injury. Toxicol Sci. 2018;165(2):420\u2013430. https:\/\/doi.org\/10.1093\/toxsci\/kfy151. PMID: 29947792.","DOI":"10.1093\/toxsci\/kfy151"},{"issue":"21","key":"4811_CR31","doi-asserted-by":"publisher","first-page":"6505","DOI":"10.3390\/jcm13216505","volume":"13","author":"JJ Wu","year":"2024","unstructured":"Wu JJ, Tung CW, Lin CW, Huang JC, Yang JT, Tsai YH, Peng YS. Serum osmolality as a predictor of renal function decline: A retrospective cohort study. J Clin Med. 2024;13(21):6505. https:\/\/doi.org\/10.3390\/jcm13216505. PMID: 39518643; PMCID: PMC11545865.","journal-title":"J Clin Med"},{"key":"4811_CR32","doi-asserted-by":"publisher","unstructured":"Gondim Fde A, Aiyagari V, Shackleford A, Diringer MN. Osmolality not predictive of mannitol-induced acute renal insufficiency. J Neurosurg. 2005;103(3):444-7. https:\/\/doi.org\/10.3171\/jns.2005.103.3.0444. PMID: 16235675.","DOI":"10.3171\/jns.2005.103.3.0444"},{"issue":"5","key":"4811_CR33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1053\/j.ajkd.2022.10.012","volume":"81","author":"KE Watson","year":"2023","unstructured":"Watson KE, Dhaliwal K, Robertshaw S, Verdin N, Benterud E, Lamont N, et al. Consensus recommendations for sick day medication guidance for people with Diabetes, Kidney, or cardiovascular disease: A modified Delphi process. Am J Kidney Dis. 2023;81(5):564\u201374.","journal-title":"Am J Kidney Dis"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04811-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04811-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04811-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:44:30Z","timestamp":1774284270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04811-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4811"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04811-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was prepared in accordance with the Declaration of Helsinki. The Clinical Research Ethics Committee of Fundaci\u00f3n Cardioinfantil \u2013 Instituto de Cardiolog\u00eda reviewed and approved the request for authorization to publish this case report (Minutes\/Acta No. 19\u20132025; CEIC\u2013203\u20132025). Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"During the preparation of this work the authors used Gemini 2.5 to correct some writing errors and improve the coherence of previously written ideas. After using this tool, the authors fully reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"181"}}